OnCare Hawaii-Liliha — Honolulu, Hawaii

OnCare Hawaii-Liliha is a clinical research site located in Honolulu, Hawaii, United States 96817-3169.

Crixeo Clinical Trials Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

OnCare Hawaii-Liliha has participated in 14 clinical trials with 2 currently active.

Therapeutic areas: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer.

Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OnCare Hawaii-Liliha?

OnCare Hawaii-Liliha has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OnCare Hawaii-Liliha conducted?

OnCare Hawaii-Liliha has 14 clinical trials on record, with 2 currently active. Their work covers Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer.

Is OnCare Hawaii-Liliha accredited by Crixeo Clinical Trials?

OnCare Hawaii-Liliha has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OnCare Hawaii-Liliha?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.